NCT00801229View on ClinicalTrials.gov

Effect of Vyvanse on Driving in Young Adults With ADHD

PHASE4CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Attention Deficit/Hyperactivity Disorder(ADHD)

Interventions

DRUG

Vyvanse

Vyvanse 30, 50, or 70 mg daily

DRUG

Placebo

Placebo 30, 50, 70 mg daily

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Shire

INDUSTRY

lead

Massachusetts General Hospital

OTHER